Pulido-Perez Ana, Sanchez-Carrillo Carlos, Bergon-Sendin Marta, Suarez-Fernandez Ricardo, Rosell-Diaz Angel Manuel, Muñoz Patricia, Bouza Emilio
Department of Dermatology, Hospital General Universitario Gregorio Marañón, C/Doctor Esquerdo 46, 28007, Madrid, Spain.
Instituto de Investigación Biomédica Gregorio Marañón, Madrid, Spain.
Eur J Clin Microbiol Infect Dis. 2022 May;41(5):779-786. doi: 10.1007/s10096-022-04431-6. Epub 2022 Mar 23.
Cutaneous manifestations developed in the course of sepsis are poorly documented in the medical literature beyond those related to specific pathogens or classical clinical pictures such as purpura fulminans or ecthyma gangrenosum. The objective of this study was to determine the overall prevalence of sepsis-related skin findings and evaluate their possible impact on the prognosis of septic patients. Single-centre, retrospective study of septic patients with documented bloodstream infections admitted in a tertiary hospital during 2019. Primary skin and soft tissue infections, and non-sepsis-related skin conditions diagnosed during hospital admission were excluded. Unselected sample of 320 episodes of sepsis in 265 patients. Secondary skin lesions were documented in 57 sepsis episodes (17.8%) in 47 patients. Purpura (petechiae/ecchymosis) was the most frequent cutaneous finding in septic patients (35.5%), with non-acral involvement in more than one-third of the episodes (38.5%), followed by skin and soft tissue erythema/oedema (25.8%) and maculopapular rashes (11.3%). Secondary skin lesions occurred more frequently in sepsis of respiratory (p = 0.027) and skin and soft tissue (p = 0.018) origin, as well as in sepsis caused by Pseudomonas aeruginosa and Stenotrophomonas maltophilia (p = 0.001). Mean hospital stay was 38.58 days and sepsis-related mortality 21.1%. Our results suggest that cutaneous involvement in the course of sepsis is frequent, with purpura being the main clinical sign. The semiology described in this study, easily identifiable by non-dermatologists, should alert clinicians to the potential unfavourable course of these patients.
除了与特定病原体或经典临床症状(如暴发性紫癜或坏疽性深脓疱)相关的情况外,脓毒症病程中出现的皮肤表现鲜有医学文献记载。本研究的目的是确定脓毒症相关皮肤表现的总体患病率,并评估其对脓毒症患者预后的可能影响。对2019年在一家三级医院收治的有血流感染记录的脓毒症患者进行单中心回顾性研究。排除原发性皮肤和软组织感染以及住院期间诊断的与脓毒症无关的皮肤疾病。对265例患者的320次脓毒症发作进行非选择性抽样。47例患者的57次脓毒症发作(17.8%)记录有继发性皮肤病变。紫癜(瘀点/瘀斑)是脓毒症患者最常见的皮肤表现(35.5%),超过三分之一的发作(38.5%)不累及手足,其次是皮肤和软组织红斑/水肿(25.8%)和斑丘疹(11.3%)。继发性皮肤病变在呼吸道(p = 0.027)和皮肤及软组织来源的脓毒症(p = 0.018)中更常见,在铜绿假单胞菌和嗜麦芽窄食单胞菌引起的脓毒症中也更常见(p = 0.001)。平均住院时间为38.58天,脓毒症相关死亡率为21.1%。我们的结果表明,脓毒症病程中皮肤受累很常见,紫癜是主要临床体征。本研究中描述的症状学,非皮肤科医生也能轻易识别,应提醒临床医生注意这些患者可能出现的不良病程。